Phase III Hallmark DUAL: ASV+DCV (Nulls/Partials, Intolerants/Ineligibles. Naives)

Clinical trial NCT01581203 · COMPLETED

Trial details

NCT number: NCT01581203
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hepatitis C Virus

Start date: 2012-05-01
Primary completion: 2013-10-01
Enrollment: 748

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.